# The Safety of Intravenous Tranexamic Acid in Patients Undergoing Supratentorial Meningiomas Resection

> **NCT04595786** · NA · COMPLETED · sponsor: **Beijing Tiantan Hospital** · enrollment: 228 (actual)

## Conditions studied

- Seizures
- Meningioma

## Interventions

- **DRUG:** Tranexamic acid
- **DRUG:** 0.9% saline

## Key facts

- **NCT ID:** NCT04595786
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-30
- **Primary completion:** 2024-01-11
- **Final completion:** 2024-07-11
- **Target enrollment:** 228 (ACTUAL)
- **Last updated:** 2025-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04595786

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04595786, "The Safety of Intravenous Tranexamic Acid in Patients Undergoing Supratentorial Meningiomas Resection". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT04595786. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*